Loading...
Market
What will be the effectiveness of CDO-7N-1 antibody against new COVID-19 variants by June 30, 2025?
2
Resolution / Starting Odds
Highly effective • 25%
Moderately effective • 25%
Slightly effective • 25%
Not effective • 25%
Peer-reviewed scientific publications and official health organization reports
Story
Texas Biomed Discovers Antibody CDO-7N-1 Neutralizing All COVID-19 Variants
Sep 10, 2024, 12:27 PM
Researchers at Texas Biomed have discovered an antibody, CDO-7N-1, that can neutralize all known variants of SARS-CoV-2, the virus responsible for COVID-19. This antibody induces immunity to all major SARS-CoV-2 proteins and is highly effective against all major variants to date. Additionally, the antibody has shown effectiveness against distantly related SARS-like coronaviruses that infect other animals. This breakthrough could have significant implications for the treatment and prevention of COVID-19 and related viral infections.
View original story
Similar markets
Less than 50% • 25%
50-70% • 25%
71-90% • 25%
More than 90% • 25%
Very Effective (>90%) • 25%
Effective (70-90%) • 25%
Moderately Effective (50-70%) • 25%
Ineffective (<50%) • 25%
Yes • 50%
No • 50%
Pfizer-BioNTech • 25%
Moderna • 25%
Novavax • 25%
Other • 25%
Pfizer (KP.2) • 25%
Moderna (KP.2) • 25%
Novavax (JN.1) • 25%
All equally effective • 25%
Yes • 50%
No • 50%
Less than 50% • 25%
50% to 70% • 25%
70% to 90% • 25%
More than 90% • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Very Effective • 25%
Moderately Effective • 25%
Slightly Effective • 25%
Not Effective • 25%